Molecular Diagnostic Biomarkers in Autism Spectrum Disorder: From Multi-Omics Signatures to Precision Therapeutic Targets
Molecules · 02.11.2026 · 31 (21) · 3952
DOI: 10.3390/molecules31213952 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 02.11.2026. Verfasst von Yanghao Zheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Mental Health Centre &Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou 310013, China. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Biomarkers. Die Arbeit nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
Autism spectrum disorder (ASD) is a systemic multi-organ condition characterized by profound biological heterogeneity. Clinical management currently faces a bottleneck due to reliance on subjective behavioral phenotyping rather than objective molecular markers. This review synthesizes breakthroughs in ASD diagnostics, moving from a reductionist “one-size-fits-all” approach toward an integrative systems biology framework. We evaluate how genetic variants and epigenetic modifications converge on shared pathways, such as synaptic homeostasis and chromatin remodeling. Furthermore, we highlight the diagnostic potential of proteomic and metabolomic signatures, which capture functional states more proximally to the clinical phenotype, including sex-specific metabotypes. The roles of neuroinflammation, oxidative stress, and the gut–microbiota–brain axis are delineated as key contributing factors of pathophysiology. Finally, we propose a roadmap for integrating multi-omics data via machine learning to facilitate early screening and precision therapeutic stratification. By bridging molecular footprints with clinical phenotyping, this synthesis provides a foundation for personalized medicine in neurodevelopmental disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Mental Health Centre &Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou 310013, China.
ORCID-Profile: Yanghao Zheng
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Postdoctoral Fellowship Program of CPSF
Zitieren
APA
Zheng, Y., & Zhao, M. (2026). Molecular Diagnostic Biomarkers in Autism Spectrum Disorder: From Multi-Omics Signatures to Precision Therapeutic Targets. Molecules, 31(21), 3952. https://doi.org/10.3390/molecules31213952
Vancouver
Zheng Y, Zhao M. Molecular Diagnostic Biomarkers in Autism Spectrum Disorder: From Multi-Omics Signatures to Precision Therapeutic Targets. Molecules. 2026;31(21):3952. doi:10.3390/molecules31213952
BibTeX
@article{Zheng2026,
author = {Zheng, Yanghao and Zhao, Mingzhe},
title = {Molecular Diagnostic Biomarkers in Autism Spectrum Disorder: From Multi-Omics Signatures to Precision Therapeutic Targets},
journal = {Molecules},
year = {2026},
volume = {31},
number = {21},
pages = {3952},
doi = {10.3390/molecules31213952}
}
EUVIMED